Advertisement

Eye and Vision

, 6:37 | Cite as

Optical coherence tomography angiography in diabetic retinopathy: a review of current applications

  • Kai Yuan Tey
  • Kelvin Teo
  • Anna C. S. Tan
  • Kavya Devarajan
  • Bingyao Tan
  • Jacqueline Tan
  • Leopold Schmetterer
  • Marcus AngEmail author
Open Access
Review
Part of the following topical collections:
  1. New frontiers of diabetic research in the eye

Abstract

Background

Diabetic retinopathy (DR) is a leading cause of vision loss in adults. Currently, the standard imaging technique to monitor and prognosticate DR and diabetic maculopathy is dye-based angiography. With the introduction of optical coherence tomography angiography (OCTA), it may serve as a potential rapid, non-invasive imaging modality as an adjunct.

Main text

Recent studies on the role of OCTA in DR include the use of vascular parameters e.g., vessel density, intercapillary spacing, vessel diameter index, length of vessels based on skeletonised OCTA, the total length of vessels, vascular architecture and area of the foveal avascular zone. These quantitative measures may be able to detect changes with the severity and progress of DR for clinical research. OCTA may also serve as a non-invasive imaging method to detect diabetic macula ischemia, which may help predict visual prognosis. However, there are many limitations of OCTA in DR, such as difficulty in segmentation between superficial and deep capillary plexus; and its use in diabetic macula edema where the presence of cystic spaces may affect image results. Future applications of OCTA in the anterior segment include detection of anterior segment ischemia and iris neovascularisation associated with proliferative DR and risk of neovascular glaucoma.

Conclusion

OCTA may potentially serve as a useful non-invasive imaging tool in the diagnosis and monitoring of diabetic retinopathy and maculopathy in the future. Future studies may demonstrate how quantitative OCTA measures may have a role in detecting early retinal changes in patients with diabetes.

Keywords

Optical coherence tomography angiography Fluorescein angiography Diabetic retinopathy Screening Monitoring 

Abbreviations

CC

Choroidal circulation

DCP

Deep Capillary Plexuses

DME

Diabetic Macula Edema

DMI

Diabetic Macula Ischemia

DR

Diabetic retinopathy

FA

Fluorescein angiography

FAZ

Foveal avascular zone

FD

Fractal dimension

ICGA

Indocyanine green angiography

ILM

Internal limiting membrane

IRMAs

Intraretinal microvascular abnormalities

IVT

Intravitreal Therapy

MAs

Microaneurysms

NPDR

Non-proliferative diabetic retinopathy

NVE

Neovascularization Elsewhere

NVG

Neovascular glaucoma

NVI

Iris neovascularization

NVs

Neovascularizations

OCT

Optical Coherence Tomography

OCTA

Optical Coherence Tomography Angiography

PD

Vessel perfusion density

PDR

Proliferative diabetic retinopathy

SCP

Superficial Capillary Plexuses

SD

Skeleton density

VD

Vessel area density

VDI

Vessel diameter index

VLD

Vascular length density

Background

Diabetes is currently on the rise with 422 million of people in the world reported to have diabetes in 2014 [1] and is a systemic disease with a multitude of complications which may involve the eyes. The most common ocular complication is diabetic retinopathy (DR), which may be asymptomatic in the early stages, however, disease progression can lead to severe vision loss [2]. Diabetic retinopathy is a leading cause of blindness in working age adults [3] and is estimated to affect 1 in 3 diabetic patients [4, 5]. Diagnosis of DR is based on clinical findings and can be divided into 2 categories - early non-proliferative diabetic retinopathy (NPDR) and more advanced proliferative diabetic retinopathy (PDR) associated with retinal ischemia and development of neovascularisation [6]. The main sight-threatening complications of DR are diabetic maculopathy, which include diabetic macular oedema (DME) and diabetic macular ischemia (DMI) [7], and complications from PDR - vitreous haemorrhage and retinal detachment [8]. Digital retinal fundus image analysis has been shown to be able to detect early DR and DME in routine DR screening [9, 10, 11]. While it has high sensitivity and specificity, it has been shown to have a low negative predictive value [11].
Fig. 1

Comparison of Fluorescein Angiography and OCTA. a & b Fluorescein angiography images of a patient with proliferative diabetic retinopathy. These FA images show patchy areas of capillary drop out and presence of neovascularizations elsewhere (NVE). c & d Corresponding OCTA images (generated via ZEISS AngioFlex) of (a) and (b) being superimposed on the FA images. The OCTA images also show areas of capillary drop out and new vessels without leakage

Optical Coherence Tomography (OCT) offers a non-invasive, rapid imaging modality that can provide imaging of the cross-sectional structures of the retina by using low-coherence interferometry to capture high resolution two dimensional images from the optical scattering from different layers of the retina [12] and is an essential tool in the detection and monitoring of DME [13], and DMI with inner retinal thinning [14]. Optical coherence tomography angiography (OCTA) is a novel use of OCT to visualise the microvasculature of the retina and choroid without the need for dye injection [15]. This is performed through repeated scans at the same location to detect the changes in OCT reflectance signal from the flow through blood vessels [16, 17]. It allows depth-resolved imaging of the retinal vasculature and is an ideal approach for various retinal conditions such as DR, retinal venous occlusion, uveitis, retinal arterial occlusion and age-related macular degeneration [18, 19].

In this review, we will discuss the role of OCTA in the evaluation and monitoring of DR, diabetic maculopathy and the anterior segment involvement in DR.

Main text

Literature search

We conducted a literature search via PUBMED database for articles written in the English language until January 1, 2019, with the following medical subject headings: “OCTA,” “OCT angiography,” “Diabetic Retinopathy,” or “Diabetes”. All papers that used OCTA were reviewed for findings in DR and bibliographies were hand-searched for further studies. Eighty-eight articles were identified, with 11 papers being excluded as they were either reviews, inter-instrumental reliability study or case report/series. There was a total of 58 prospective studies, of which 17 were observational, 30 were observational and cross-sectional, and 11 were observational case-control study. There was a total of 19 retrospective studies, of which 12 were observational, two were observational cross-sectional, two were case-control and three were cross-sectional. In total, there were two multi-centred studies. The number of patients vary widely among studies. In addition to that, we also performed an additional search via PUBMED database with the following medical subject headings: “OCTA”, “Anterior Segment”, which returned 27 articles, of which three articles were excluded as they were either reviews or case-report.

Fluoresceine angiography and optical coherence tomography

Fluorescein angiography (FA) is helpful in the evaluation of the retinal vasculature and was first described in 1961 and later adopted as a standard practice in the field of Ophthalmology [20]. Fluorescein angiography can be used to evaluate the retinal vasculature to monitor the progression of DR and DME [21, 22]. In FA, sodium fluorescein is injected intravenously and with the use of excitation and barrier filters, high contrast en face images of the retinal vasculature can be visualised [23]. The advantage of FA lies in its ability to assess properties such as perfusion (e.g., arm-retinal time, arterio-venous transit), leakage and staining [24]. Flash photography and recently, scanning laser ophthalmoscopy can be used to capture FA images to allow visualisation of the retinal vessels in high contrast [25, 26]. With ultra-widefield FA, the imaging field can visualise the entire posterior segment and extend beyond the equator of the eye, giving a field of view of up to 200 degrees [27].

FA is a primary en face modality, and cross-sectional segmentation of the retinal vessels is not possible [28]. Depth resolution is inferred from FA, and indocyanine green angiography (ICGA) can be used to differentiate choroidal from retinal perfusion as it has a larger molecule size [28].

On the other hand, OCTA has several advantages over dye angiography in terms of acquisition speed and imaging information (Fig. 1) [28]. OCTA images are essentially motion-contrast images with images obtained via multiple B scans at the same location, and information derived is based on the backscattering of light from the changes in the intensity and phase from each scan changes due to blood flow while the neurosensory tissue will remain stationary, henceforth this approach eliminates the need for dye. The primary advantage of OCTA is the ability to obtain depth-resolved imaging of the retinal vasculature [29]. It is able to generate the images of the superficial and deep retinal layers by default [30] and this can be modified to further segment the retinal vasculature and provide images of other layers such as the radial peripapillary network and choriocapillaris [28, 31, 32], which can help to visualise pathological features that are not previously seen in 2-layers segmentation [32]. The corresponding flow signal on OCT B-scans allows cross-sectional localization of the vasculature in question.

There are several shortcomings for OCTA use. Firstly, the field of view of OCTA is narrower than FA, with most images being 3 mm by 3 mm [28]. The largest scanning area that is achievable with commercially available OCTA devices is 8 mm by 8 mm which grants a field of view of approximately 30 degrees [33]. Thus, OCTA has poor ability in generating good quality peripheral retinal images [28]. Even with the introduction of wide-field OCTA that is able to generate images of 12 mm by 12 mm the field of view is still not comparable to standard and ultra wide-field FA/ICGA [34, 35]. To overcome this limitation, the montaging algorithm has been introduced which allows the 12 mm by 12 mm images to be montaged and generate a wider field of view [28]. This approach, however, results in an increase of scan acquisition time, and inherent inaccuracies due to misalignment of images [36]. Secondly, OCTA is unable to assess dynamic characteristics of flow velocity, and leakage which is sometimes necessary to assess various retina pathology. Thirdly, processing of high-resolution images can be time-consuming [37] and images generated via OCTA are highly susceptible to projection artefacts due to the presence of the superficial blood flows resulting in difficulty in interpreting the deep retinal vasculatures [38]. While this can be corrected via projection removal algorithms, this method may potentially result in loss of flow information within the deeper layer, giving a disjointed image [39]. Additionally, OCTA images are prone to motion artefacts as well, which often appear as a white line across the image, and can be improved with motion correction function and eye-tracking algorithm [40].

Morphological changes of DR on OCTA

Several morphological changes of DR can be detected by OCTA – microaneurysms (MAs), intraretinal microvascular abnormalities (IRMAs), nonperfusion areas and neovascularizations (NVs) [41], and it is able to offer additional information with respect to the localization of these changes [42].

Microaneurysms are lesions that often manifest in early DR. Thompson et al. showed that OCTA is able to pick up MAs, not otherwise shown on a dilated clinical examination [43]. OCTA is able to localize MAs precisely [42]. There are, however, discrepancies, among studies, in regards to the detectability of MAs between FA and OCTA [42, 44, 45, 46]. FA has demonstrated higher sensitivity compared to OCTA [47, 48, 49]. On the other hand, the majority of MAs detected by OCTA has a corresponding finding in FA [45]. Schwartz et al. and Ishibazawa et al. demonstrated that OCTA can detect MAs that are otherwise not detectable on FA [42, 46]. Detection of MAs using OCTA, however, may be influenced by blood flow turbulence within the MAs [50] and hence the discrepancy found among the studies [41, 48, 51, 52]. Parravano et al. have identified a correlation between the MAs’ reflectivity and its detectability on OCTA – MAs that are hyper-reflective are more likely to be detected but this may also be affected by turbulent blood flow in MAs [53]. As such, it is still unclear if OCTA is comparable to FA in terms of detecting MAs.

Intraretinal microvascular abnormalities are shunt vessels due to abnormal branching or dilation of existing capillaries within the retina that help to supply areas of non-perfusion in DR. Visualisation of IRMAs has been made possible with OCTA via the use of en face images and are shown as dilated or looping vessels near the areas of capillary loss, and has a higher detection rate on OCTA than color fundus photography [54]. The use of OCTA also allows identification of other features such as the presence of intraretinal hyperreflective dots and outpouching of the internal limiting membrane (ILM) [55], which may be useful in detection of IRMAs.

Retinal NVs are detectable on OCTA via observation of flow signal above the ILM [55]. OCTA can detect early retinal NVs [49] and identify the origins and morphological patterns of NVs in PDR, hence allowing classification of the lesion, offering a better understanding of the pathophysiology and helps to guide the management strategies [56]. OCTA is also able to detect subtle NVs, which is difficult to differentiate from a MAs on FA [49].

Owing to OCTA’s ability to segment the various layer of the retina, it is able to distinguish retinal NVs from IRMAs, which may not always be possible on FA or clinical examination [44], and is of importance as very often, retinal NVs may form next to IRMA [55]. In addition to that, de Carlo et al. showed that retinal NVs often appear next to retinal non-perfusion areas [55]. As such, OCTA may be useful in helping us to differentiate NPDR from DR, and aid us in following up and management planning.

Quantitative measures in OCTA and its application in DR

Various quantitative measures have been developed over the years to aid research studies as well as the understanding of DR pathophysiology. These quantitative measurements have been shown to allow objective identification and staging of NPDR – mild, moderate and severe, with significant diagnostic accuracy and predictability of DR progression [57]. To the best of our knowledge, we are not aware of any normal data material available for the different OCTA measurements. Several OCTA vascular quantitative measures currently used in research and has yet to be adopted in clinical practice have been proposed:
  1. 1)

    The area filled by binarized vessels (vessel area density – VD or vessel perfusion density - PD) [57, 58, 59, 60];

     
  2. 2)

    Vessel spacing/inter-capillary area [61];

     
  3. 3)

    Length of the blood vessel based on the skeletonized OCTA (vascular length density – VLD or skeleton density - SD) [57, 59];

     
  4. 4)

    Vessel diameter index (VDI) [57];

     
  5. 5)

    Total length of vessels (vessel length fraction) [62];

     
  6. 6)

    Vascular architecture and branching, (vessel tortuosity and fractal dimension – FD) [58];

     
  7. 7)

    Area of the foveal avascular zone – FAZ [63].

     

Certain commercially available devices – Topcon DRI-OCT Triton Swept-source OCT, Optovue RTVue-XR, Heidelberg-Engineering and Zeiss Cirrus 5000-HD-OCT enhance efficiency and reduce bias as they automatically map VD, FAZ and PD [64, 65]. In general, VD, SD, FD and VDI are highly reproducible among graders and studies have found that vascular changes in DR may be characterized by these parameters [66].

Vessel density

Vessel density is defined as the proportion of blood vessel area over the total measured area [67]. Measurements of VD are highly reproducible and comparisons of measurement should be made using the same device [67]. This parameter varies with age and sex, and should be taken into consideration when interpreting the results [68]. Vessel density also changes with retinal structural characteristics including retinal thickness and volume, and a reduced VD would correlate with thinner macular ganglion cell or inner plexiform layer [69]. Vessel density decreases in both the DCP and SCP of a patient with DR [70], as well as a diabetic patient without DR, attributing to the fact that parafoveal capillary nonperfusion in DCP may potentially be an early sign of DR [70, 71, 72, 73].

Vessel density in DCP may predict DR severity and identify patients at risk as it is able to detect retinal vascular changes in diabetic patients without any signs of DR [71, 74]. Vascular spacing and alterations in VD in SCP, however, have found to have a stronger correlation with the severity of DR as compared to VD in DCP, PD in SCP or FAZ area [68, 70, 71]. Despite the contradictory results, VD has shown to decrease in both DCP and SCP in DR, and hence able to assist in predicting treatment outcome along with following up of patients (Fig. 2) [71, 74].
Fig. 2

A series of montaged OCTA in patients with diabetic retinopathy (DR). This is a series of montaged OCTA images 15 mm × 15 mm taken at different segment in the right eye of a male (a-h) with DR. a Foveal avascular zone; b Choriocapillaris; c Choroid; d Deep capillary plexuses; e Outer-retina-choroid complex; f Retina; g Superficial capillary plexuses; h Vitreoretinal interface

Inter-capillary spacing

Inter-capillary spacing can be detected by areas that are not perfused and occur much earlier than VD changes [60]. Bhanushali et al. found that large vessel spacing, especially those in the SCP, are more sensitive than VD and FAZ area in the diagnosis of DR and it reflects the severity of DR [74]. The extrafoveal avascular area may help to distinguish early NPDR from healthy eyes [75]. Schottenhamml et al. found that inter-capillary space-based algorithm is more sensitive than vascular density-based methods to calculate early capillary drop-out or non-perfusion areas [61]. As capillary non-perfusion area enlarges with progression in severity of DR, the quantitative analysis of retinal non-perfusion on OCTA may be useful for early detection and monitoring of disease in patients with diabetes and DR [76].

Vascular architecture and branching – vessel tortuosity and fractal dimension

Vessel tortuosity is a quantitative measure from fundus images via computer-assisted software and is defined as the integral of the curvature square along the path of vessel, normalized by the total path length [77]. Patients with diabetes have been found to have increased vessel tortuosity as compared to healthy controls and are related to mild and moderate stages of DR, suggesting that vessel tortuosity may be an early indicator of microvascular damage in the retina [78]. Vessel tortuosity may be used to distinguish moderate to severe NPDR from PDR, particularly in the SCP region. FAZ area and acircularity correlate with vessel tortuosity in 3 mm2 and 1.5 mm2 of SCP. As this parameter increases with worsening of NPDR and decreases in PDR, it may serve as a quantitative marker to monitor the progression of DR [58].

Fractal dimension is a measure of the complexity of a vasculature branching pattern [79] and is derived from applying fractal analysis to OCTA images [80]. Fractal dimension was found to be an early indicator of DR [81] and was reduced in both SCP and DCP in patients with diabetes compared to healthy controls, with a greater reduction in the DCP [82, 83].

Foveal avascular zone assessment

Johannesen et al. [84] conducted a systemic review on 8 studies investigating the changes in the FAZ in DR patients. Seven of these studies found that the FAZ in NPDR patients will be larger as compared with the healthy control group. Six studies on OCTA in DR found that patients with PDR have a larger FAZ as compared to the control group, and a decrease in foveal capillary perfusion in diabetics compared to controls. This increase in FAZ with the progression of DR may indicate increasing non-perfusion [85].

Use of OCTA in macula disease in DR

Diabetic macular ischemia is characterized by the occlusion and loss of the macular capillary network or capillary dropout [86]. A study showed that non-perfused areas in DCP and reduced VD reflect the macular photoreceptor disruption in DMI [86, 87]. In the area of the disrupted ellipsoid zone of the photoreceptor, choroidal circulation (CC) layer had greater areas of flow void and hence alteration of CC appears to play a role in the pathogenesis of DR and DMI [88]. Wide-field OCTA images have shown that large arterioles situated in both superficial and deep layers seem to be the perfusion boundaries, which may serve as a novel anatomic factor to predict the likelihood of non-perfusion development (Fig. 3) [89] While FA is the gold standard for diagnosing DMI, OCTA may be able to do so as well [21, 86] since OCTA may provide images with higher details with respect to macular status [86] and high intergrader agreement [21]. Vascular quantitative measures of OCTA have also shown to be able to help screen and monitor DMI in patients with no clinical evidence of DR [90]. With further advancement in the technology, OCTA may serve as an alternative non-invasive method to FA to detect DMI and help predict visual prognosis.
Fig. 3

Monitoring of treatment outcome in patients with proliferative diabetic retinopathy using OCTA. This is a series of OCTA images of a 26 years old female with proliferative diabetic retinopathy taken at baseline (a & b), 1st month (c & d) and 6th month (e & f) post IVT treatment (bevacizumab). OCTA is able to detect changes - NVE regression is noted

Diabetic macular edema refers to the accumulation of fluid in the macula due to leaking blood vessels. While OCT can illustrate structural changes prominently and help in the detection of these cystic spaces [91], OCTA has low reliability in visualizing the DCP in patients with DME [92]. The accumulated fluid may interfere with imaging and segmentation capabilities of OCT as accurate identification of anatomical landmarks is needed for the complex automated process needed for correct segmentation, and incorrect segmentation may affect OCTA images [36]. DME has an inverse relationship with OCTA signal intensity [93] because the fluid weakens the reflected signal from deeper layers [94]. Spaide et al. reported that the rate of flow voiding does not match with the cystic space exactly as the vessels may be compressed by the cystic space or fluid may pool in the region of low flow rate in the DCP [95].

Regardless, Lee et al. overcame the segmentation issues by carefully adjusting the boundary between the SCP and DCP in the eyes with severe DME, and demonstrated that patients with DME exhibit significant damage to the integrity of the DCP but not the SCP [92]. It was also demonstrated that OCTA was able to assist us in quantifying macular perfusion [96] and measuring the FAZ in patients with DME [96, 97]. Using an inner segmentation of the inner retinal border and an outer segmentation of the retinal pigment epithelium, details of the macula perfusion can still be obtained in the presence of DME even though it may be difficult to differentiate between the SCP and DCP [40].

Anterior segment optical coherence tomography angiography in diabetes mellitus

Healthy iris vasculature comprises a major arterial circle that is supplied by the anterior and long posterior ciliary arteries, and a minor arterial circle found along the border of the pupil linked by radially oriented vessels within the iris stroma. In severe stages of DR, new vessels are not confined to the retina; these can grow around the pupillary border, the root of iris and can penetrate the anterior surface of the iris in severe cases. This is known as iris neovascularization (NVI) or rubeosis which can lead to the potentially sight-threatening complication of neovascular glaucoma (NVG) [98]. It is crucial to detect NVI in its early stage as prompt treatment may prevent NVG. This complication is usually diagnosed clinically by gonioscopy and although FA may help, this is not frequently the modality of choice. A potential alternative is the use of OCTA adapted for the anterior segment [99]. While current commercially available OCTA is designed to examine the posterior segment of the eye, an adapter lens can be used to provide high-quality images of the anterior segment vasculature with a good inter-observer agreement for qualitative measurements [100]. Early studies demonstrated a method of obtaining OCTA images of the cornea and limbal vasculature with great consistency [101] and allow us to compare normal and diseased iris vessels in the detection of NVI [102].

Adapting OCTA for anterior segment does come with several downsides. Specialised anterior segment adaptive lenses have to be used [57, 101] and current software are meant for imaging the posterior segment, therefore resulting in non-parallel segmentation and artefacts due to the curvature of the cornea [103]. Anterior segment OCTA is incapable of registering scans and providing localization required for comparison of serial scans [100, 104]. In addition, motion artefacts are common in anterior scans due to a lack of motion correction software [105].

Furthermore, anterior segment OCTA is not able to visualise deeper vessels in eyes with corneal opacities, dense iris pigmentation, or vessels in thick iris tumours. It has poor detection of vessels with minimal flow since the flow of erythrocytes are slower in small calibre vessels and may be below the detection threshold. Since OCTA are optimized for the posterior segment which has mainly traversing blood flows in the vessels, anterior segment vessels with axial flow may not be detected [106].

Conclusion

OCTA may potentially serve as a good alternative in the diagnosis and monitoring of diabetic retinopathy and maculopathy due to its non-invasiveness nature. However, the current quantitative measures developed have been more useful in research studies and their clinical implications are not yet well established. At the moment, these measures are not necessary for the diagnosis and monitoring of DR and its associated complications as there are existing methods that are clinically proven to be useful. However, with more studies being done in the near future, these quantitative OCTA measures may have a role in detecting subclinical disease. Anterior segment OCTA, especially in the imaging of the iris, may also be a useful biomarker in monitoring the progression of DR and potentially prevent severe complications.

Notes

Acknowledgements

Not applicable

Authors’ contributions

All authors contributed equally in this work. All authors read and approved the final manuscript.

Funding

Not applicable

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    World Health Organisation. Global report on diabates. Geneva: World Health Organisation; 2016.Google Scholar
  2. 2.
    Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care. 2003;26(suppl 1):s99–s102.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945–50.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):546–51.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Zhang X, Saaddine JB, Chou C-F, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–56.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Kumar V, Abbas AK, Fausto N, Aster JC. Diabetes mellitus. In: Schmitt W, Gruliow R, editors. Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: Elsevier Inc; 2007. p. 775–87.Google Scholar
  7. 7.
    Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathya systematic review. JAMA. 2007;298(8):902–16.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Nentwich MM, Ulbig MW. Diabetic retinopathy - ocular complications of diabetes mellitus. World J Diabetes. 2015;6(3):489–99.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Saari JM, Summanen P, Kivelä T, Saari KM. Sensitivity and specificity of digital retinal images in grading diabetic retinopathy. Acta Ophthalmol Scand. 2004;82(2):126–30.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Goh JK, Cheung CY, Sim SS, Tan PC, Tan GS, Wong TY. Retinal imaging techniques for diabetic retinopathy screening. J Diabetes Sci Technol. 2016;10(2):282–94.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    D’Aloisio R, Giglio R, Di Nicola M, De Giacinto C, Pastore MR, Tognetto D, et al. Diagnostic accuracy of digital retinal fundus image analysis in detecting diabetic maculopathy in type 2 diabetes mellitus. Ophthalmic Res. 2019;61(2):100–6.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Youngquist RC, Carr S, Davies DE. Optical coherence-domain reflectometry: a new optical evaluation technique. Opt Lett. 1987;12(3):158–60.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Virgili G, Menchini F, Casazza G, Hogg R, Das RR, Wang X, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD008081.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Sim DA, Keane PA, Fung S, Karampelas M, Sadda SR, Fruttiger M, et al. Quantitative analysis of diabetic macular ischemia using optical coherence tomographyoct features of diabetic macular ischemia. Invest Ophthalmol Vis Sci. 2014;55(1):417–23.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Fingler J, Readhead C, Schwartz DM, Fraser SE. Phase-contrast OCT imaging of transverse flows in the mouse retina and choroid. Invest Ophthalmol Vis Sci. 2008;49(11):5055–9.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Hagag AM, Gao SS, Jia Y, Huang D. Optical coherence tomography angiography: Technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol. 2017;7(3):115–29.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Ang M, Tan ACS, Cheung CMG, Keane PA, Dolz-Marco R, Sng CCA, et al. Optical coherence tomography angiography: a review of current and future clinical applications. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):237–45.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Agarwal A, Grewal DS, Jaffe GJ, Stewart MW, Srivastava S, Gupta V. Current role of optical coherence tomography angiography: Expert panel discussion. Indian J Ophthalmol. 2018;66(12):1696–9.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Tan ACS, Tan GS, Denniston AK, Keane PA, Ang M, Milea D, et al. An overview of the clinical applications of optical coherence tomography angiography. Eye (Lond). 2018;32(2):262–86.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Gass JDM, Sever RJ, Sparks D, Goren J. A combined technique of fluorescein funduscopy and angiography of the eye. Arch Ophthalmol. 1967;78(4):455–61.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Bradley PD, Sim DA, Keane PA, Cardoso J, Agrawal R, Tufail A, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography OCTA in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(2):626–31.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Salz DA, Witkin AJ. Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol. 2015;22(2):145–50.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Kim DY, Fingler J, Zawadzki RJ, Park SS, Morse LS, Schwartz DM, et al. Optical imaging of the chorioretinal vasculature in the living human eye. Proc Natl Acad Sci U S A. 2013;110(35):14354–9.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Shiraki K, Moriwaki M, Yanagihara N, Kohno T, Miki T. Indocyanine green angiograms of choroidal nevi: comparison between confocal and nonconfocal scanning laser ophthalmoscope and fundus video camera. Jpn J Ophthalmol. 2001;45(4):368–74.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Bartsch DU, Weinreb RN, Zinser G, Freeman WR. Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol. 1995;120(5):642–51.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Klufas MA, Yannuzzi NA, Pang CE, Srinivas S, Sadda SR, Freund KB, et al. Feasibility and clinical utility of ultra-widefield indocyanine green angiography. Retina. 2015;35(3):508–20.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous. 2015;1:5.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Chua J, Chin CWL, Tan B, Wong SH, Devarajan K, Le TT, et al. Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension. Sci Rep. 2019;9(1):5819.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Garrity ST, Iafe NA, Phasukkijwatana N, Chen X, Sarraf D. Quantitative analysis of three distinct retinal capillary plexuses in healthy eyes using optical coherence tomography angiographyquantitative analysis using OCTA. Invest Ophthalmol Vis Sci. 2017;58(12):5548–55.PubMedCrossRefGoogle Scholar
  31. 31.
    Guo Y, Camino A, Zhang M, Wang J, Huang D, Hwang T, et al. Automated segmentation of retinal layer boundaries and capillary plexuses in wide-field optical coherence tomographic angiography. Biomed Opt Express. 2018;9(9):4429–42.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Hwang TS, Zhang M, Bhavsar K, Zhang X, Campbell JP, Lin P, et al. Visualization of 3 distinct retinal plexuses by projection-resolved optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(12):1411–9.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Salas M, Augustin M, Felberer F, Wartak A, Laslandes M, Ginner L, et al. Compact akinetic swept source optical coherence tomography angiography at 1060 nm supporting a wide field of view and adaptive optics imaging modes of the posterior eye. Biomed Opt Express. 2018;9(4):1871–92.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Tian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR. Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2019;103(9):1289–95.PubMedCrossRefGoogle Scholar
  35. 35.
    Sawada O, Ichiyama Y, Obata S, Ito Y, Kakinoki M, Sawada T, et al. Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1275–80.PubMedCrossRefGoogle Scholar
  36. 36.
    Sorour O, Arya M, Waheed N. New findings and challenges in OCT angiography for diabetic retinopathy. Ann Eye Sci. 2018;3(8):44–44.CrossRefGoogle Scholar
  37. 37.
    Pichi F, Sarraf D, Morara M, Mazumdar S, Neri P, Gupta V. Pearls and pitfalls of optical coherence tomography angiography in the multimodal evaluation of uveitis. J Ophthalmic Inflamm Infect. 2017;7(1):20.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Zhang Q, Lee CS, Chao J, Chen CL, Zhang T, Sharma U, et al. Wide-field optical coherence tomography based microangiography for retinal imaging. Sci Rep. 2016;6:22017.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Nesper PL, Soetikno BT, Zhang HF, Fawzi AA. OCT angiography and visible-light OCT in diabetic retinopathy. Vis Res. 2017;139:191–203.PubMedCrossRefGoogle Scholar
  40. 40.
    Sambhav K, Grover S, Chalam KV. The application of optical coherence tomography angiography in retinal diseases. Surv Ophthalmol. 2017;62(6):838–66.PubMedCrossRefGoogle Scholar
  41. 41.
    Matsunaga DR, Yi JJ, De Koo LO, Ameri H, Puliafito CA, Kashani AH. Optical coherence tomography angiography of diabetic retinopathy in human subjects. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):796–805.PubMedCrossRefGoogle Scholar
  42. 42.
    Ishibazawa A, Nagaoka T, Takahashi A, Omae T, Tani T, Sogawa K, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160(1):35–44.e1.PubMedCrossRefGoogle Scholar
  43. 43.
    Thompson IA, Durrani AK, Patel S. Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy. Eye (Lond). 2019;33(4):648–52.CrossRefGoogle Scholar
  44. 44.
    Yu S, Lu J, Cao D, Liu R, Liu B, Li T, et al. The role of optical coherence tomography angiography in fundus vascular abnormalities. BMC Ophthalmol. 2016;16:107.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Miwa Y, Murakami T, Suzuma K, Uji A, Yoshitake S, Fujimoto M, et al. Relationship between functional and structural changes in diabetic vessels in optical coherence tomography angiography. Sci Rep. 2016;6:29064.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Schwartz DM, Fingler J, Kim DY, Zawadzki RJ, Morse LS, Park SS, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology. 2014;121(1):180–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Hamada M, Ohkoshi K, Inagaki K, Ebihara N, Murakami A. Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images. Jpn J Ophthalmol. 2018;62(2):168–75.PubMedCrossRefGoogle Scholar
  48. 48.
    Couturier A, Mané V, Bonnin S, Erginay A, Massin P, Gaudric A, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11):2384–91.PubMedCrossRefGoogle Scholar
  49. 49.
    Hwang TS, Jia Y, Gao SS, Bailey ST, Lauer AK, Flaxel CJ, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371–6.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Nakao S, Yoshida S, Kaizu Y, Yamaguchi M, Wada I, Ishibashi T, et al. Microaneurysm detection in diabetic retinopathy using OCT angiography may depend on intramicroaneurysmal turbulence. Ophthalmol Retina. 2018;2(11):1171–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Arend O, Wolf S, Jung F, Bertram B, Pöstgens H, Toonen H, et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75(9):514–8.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Schreur V, Domanian A, Liefers B, Venhuizen FG, Klevering BJ, Hoyng CB, et al. Morphological and topographical appearance of microaneurysms on optical coherence tomography angiography. Br J Ophthalmol. 2018;103(5):630–5.CrossRefGoogle Scholar
  53. 53.
    Parravano M, De Geronimo D, Scarinci F, Querques L, Virgili G, Simonett JM, et al. Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection. Am J Ophthalmol. 2017;179:90–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Schaal KB, Munk MR, Wyssmueller I, Berger LE, Zinkernagel MS, Wolf S. Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging. Retina. 2019;39(1):79–87.PubMedCrossRefGoogle Scholar
  55. 55.
    de Carlo TE, Bonini Filho MA, Baumal CR, Reichel E, Rogers A, Witkin AJ, et al. Evaluation of preretinal neovascularization in proliferative diabetic retinopathy using optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):115–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Pan J, Chen D, Yang X, Zou R, Zhao K, Cheng D, et al. Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography. Am J Ophthalmol. 2018;192:146–56.PubMedCrossRefGoogle Scholar
  57. 57.
    Alam M, Zhang Y, Lim JI, Chan RVP, Yang M, Yao X. Quantitative optical coherence tomography angiography features for objective classification and staging of diabetic retinopathy. Retina. 2018.  https://doi.org/10.1097/IAE.0000000000002373.
  58. 58.
    Lee H, Lee M, Chung H, Kim HC. Quantification of retinal vessel tortuosity in diabetic retinopathy using optical coherence tomography angiography. Retina. 2018;38(5):976–85.PubMedCrossRefGoogle Scholar
  59. 59.
    Uji A, Balasubramanian S, Lei J, Baghdasaryan E, Al-Sheikh M, Sadda SR. Impact of multiple en face image averaging on quantitative assessment from optical coherence tomography angiography images. Ophthalmology. 2017;124(7):944–52.PubMedCrossRefGoogle Scholar
  60. 60.
    Anegondi N, Kshirsagar A, Mochi TB, Sinha RA. Quantitative comparison of retinal vascular features in optical coherence tomography angiography images from three different devices. Ophthalmic Surg Lasers Imaging Retina. 2018;49(7):488–96.PubMedCrossRefGoogle Scholar
  61. 61.
    Schottenhamml J, Moult EM, Ploner S, Lee B, Novais EA, Cole E, et al. An automatic, intercapillary area-based algorithm for quantifying diabetes-related capillary dropout using optical coherence tomography angiography. Retina. 2016;36(Suppl 1):S93–S101.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Pedinielli A, Bonnin S, El Sanharawi M, Mané V, Erginay A, Couturier A, et al. Three different optical coherence tomography angiography measurement methods for assessing capillary density changes in diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2017;48(5):378–84.PubMedCrossRefGoogle Scholar
  63. 63.
    Lu Y, Simonett JM, Wang J, Zhang M, Hwang T, Hagag AM, et al. Evaluation of automatically quantified foveal avascular zone metrics for diagnosis of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2018;59(6):2212–21.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Lee MW, Kim KM, Lim HB, Jo YJ, Kim JY. Repeatability of vessel density measurements using optical coherence tomography angiography in retinal diseases. Br J Ophthalmol. 2018;103(5):704–10.CrossRefGoogle Scholar
  65. 65.
    Munk MR, Giannakaki-Zimmermann H, Berger L, Huf W, Ebneter A, Wolf S, et al. OCT-angiography: a qualitative and quantitative comparison of 4 OCT-A devices. PLoS One. 2017;12(5):e0177059.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Tang FY, Ng DS, Lam A, Luk F, Wong R, Chan C, et al. Determinants of quantitative optical coherence tomography angiography metrics in patients with diabetes. Sci Rep. 2017;7(1):2575.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    You Q, Freeman WR, Weinreb RN, Zangwill L, Manalastas PIC, Saunders LJ, et al. Reproducibility of vessel density measurement with optical coherence tomography angiography in eyes with and without retinopathy. Retina. 2017;37(8):1475–82.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Durbin MK, An L, Shemonski ND, Soares M, Santos T, Lopes M, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135(4):370–6.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Dimitrova G, Chihara E, Takahashi H, Amano H, Okazaki K. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(1):190–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-source oct angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathyoct-angiography in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(8):3907–13.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Carnevali A, Sacconi R, Corbelli E, Tomasso L, Querques L, Zerbini G, et al. Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol. 2017;54(7):695–702.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Cicinelli MV, Carnevali A, Rabiolo A, Querques L, Zucchiatti I, Scorcia V, et al. Clinical spectrum of macular-foveal capillaries evaluated with optical coherence tomography angiography. Retina. 2017;37(3):436–43.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Ting DSW, Tan GSW, Agrawal R, Yanagi Y, Sie NM, Wong CW, et al. Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathyoct angiography in type 2 diabetes and diabetic retinopathyoct angiography in type 2 diabetes and diabetic retinopathy. JAMA Ophthalmol. 2017;135(4):306–12.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Bhanushali D, Anegondi N, Gadde SG, Srinivasan P, Chidambara L, Yadav NK, et al. Linking retinal microvasculature features with severity of diabetic retinopathy using optical coherence tomography angiographyretinal vasculature changes in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(9):OCT519–25.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Zhang M, Hwang TS, Dongye C, Wilson DJ, Huang D, Jia Y. Automated quantification of nonperfusion in three retinal plexuses using projection-resolved optical coherence tomography angiography in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(13):5101–6.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Alibhai AY, De Pretto LR, Moult EM, Or C, Arya M, McGowan M, et al. Quantification of retinal capillary nonperfusion in diabetics using wide-field optical coherence tomography angiography. Retina. 2018.  https://doi.org/10.1097/IAE.0000000000002403.
  77. 77.
    Cheung CY, Zheng Y, Hsu W, Lee ML, Lau QP, Mitchell P, et al. Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors. Ophthalmology. 2011;118(5):812–8.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia. 2011;54(9):2409–16.PubMedCrossRefGoogle Scholar
  79. 79.
    Huang F, Dashtbozorg B, Zhang J, Bekkers E, Abbasi-Sureshjani S, Berendschot TTJM, et al. Reliability of using retinal vascular fractal dimension as a biomarker in the diabetic retinopathy detection. J Ophthalmol. 2016;2016:6259047.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Zahid S, Dolz-Marco R, Freund KB, Balaratnasingam C, Dansingani K, Gilani F, et al. Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(11):4940–7.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Chen Q, Ma Q, Wu C, Tan F, Chen F, Wu Q, et al. Macular vascular fractal dimension in the deep capillary layer as an early indicator of microvascular loss for retinopathy in type 2 diabetic patientsmicrovascular fractals in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2017;58(9):3785–94.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Michalska-Małecka K, Heinke KA. Optical coherence tomography angiography in patients with diabetic retinopathy treated with anti-VEGF intravitreal injections: case report. Medicine (Baltimore). 2017;96(45):e8379.CrossRefGoogle Scholar
  83. 83.
    Bhardwaj S, Tsui E, Zahid S, Young E, Mehta N, Agemy S, et al. Value of fractal analysis of optical coherence tomography angiography in various stages of diabetic retinopathy. Retina. 2018;38(9):1816–23.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Johannesen SK, Viken JN, Vergmann AS, Grauslund J. Optical coherence tomography angiography and microvascular changes in diabetic retinopathy: a systematic review. Acta Ophthalmol. 2019;97(1):7–14.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Salz DA, de Carlo TE, Adhi M, Moult E, Choi W, Baumal CR, et al. Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes. JAMA Ophthalmol. 2016;134(6):644–50.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Garcia JM, Lima TT, Louzada RN, Rassi AT, Isaac DL, Avila M. Diabetic macular ischemia diagnosis: comparison between optical coherence tomography angiography and fluorescein angiography. J Ophthalmol. 2016;2016:3989310.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Nesper PL, Scarinci F, Fawzi AA. Adaptive optics reveals photoreceptor abnormalities in diabetic macular ischemia. PLoS One. 2017;12(1):e0169926.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Dodo Y, Suzuma K, Ishihara K, Yoshitake S, Fujimoto M, Yoshitake T, et al. Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography. Sci Rep. 2017;7(1):5227.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Yasukura S, Murakami T, Suzuma K, Yoshitake T, Nakanishi H, Fujimoto M, et al. Diabetic nonperfused areas in macular and extramacular regions on wide-field optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2018;59(15):5893–903.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Yasin Alibhai A, Moult EM, Shahzad R, Rebhun CB, Moreira-Neto C, McGowan M, et al. Quantifying microvascular changes using OCT angiography in diabetic eyes without clinical evidence of retinopathy. Ophthalmol Retina. 2018;2(5):418–27.CrossRefGoogle Scholar
  91. 91.
    Musat O, Cernat C, Labib M, Gheorghe A, Toma O, Zamfir M, et al. Diabetic macular edema. Rom J Ophthalmol. 2015;59(3):133–6.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Lee J, Moon BG, Cho AR, Yoon YH. Optical coherence tomography angiography of dme and its association with anti-vegf treatment response. Ophthalmology. 2016;123(11):2368–75.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Toto L, D'Aloisio R, Di Nicola M, Di Martino G, Di Staso S, Ciancaglini M, et al. Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography. Int J Mol Sci. 2017;18(6):1181.PubMedCentralCrossRefGoogle Scholar
  94. 94.
    de Carlo TE, Chin AT, Joseph T, Baumal CR, Witkin AJ, Duker JS, et al. Distinguishing diabetic macular edema from capillary nonperfusion using optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):108–14.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Spaide RF. Volume-rendered optical coherence tomography of diabetic retinopathy pilot study. Am J Ophthalmol. 2015;160(6):1200–10.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    AttaAllah HR, Mohamed AAM, Ali MA. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography. Int Ophthalmol. 2018;39(8):1845–59.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Gill A, Cole ED, Novais EA, Louzada RN, de Carlo T, Duker JS, et al. Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography. Int J Retina Vitreous. 2017;3:19.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Mishra A, Luthra S, Baranwal VK, Parihar JKS. An interesting case of rubeosis iridis with neovascular glaucoma in a young patient. Med J Armed Forces India. 2013;69(2):187–9.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Lee WD, Devarajan K, Chua J, Schmetterer L, Mehta JS, Ang M. Optical coherence tomography angiography for the anterior segment. Eye Vis (Lond). 2019;6:4.CrossRefGoogle Scholar
  100. 100.
    Ang M, Baskaran M, Werkmeister RM, Chua J, Schmidl D, Aranha Dos Santos V, et al. Anterior segment optical coherence tomography. Prog Retin Eye Res. 2018;66:132–56.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Ang M, Sim DA, Keane PA, Sng CC, Egan CA, Tufail A, et al. Optical coherence tomography angiography for anterior segment vasculature imaging. Ophthalmology. 2015;122(9):1740–7.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Roberts PK, Goldstein DA, Fawzi AA. Anterior segment optical coherence tomography angiography for identification of iris vasculature and staging of iris neovascularization: a pilot study. Curr Eye Res. 2017;42(8):1136–42.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Brunner M, Romano V, Steger B, Vinciguerra R, Lawman S, Williams B, et al. Imaging of corneal neovascularization: optical coherence tomography angiography and fluorescence angiography. Invest Ophthalmol Vis Sci. 2018;59(3):1263–9.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Ang M, Cai Y, Shahipasand S, Sim DA, Keane PA, Sng CC, et al. En face optical coherence tomography angiography for corneal neovascularisation. Br J Ophthalmol. 2016;100(5):616–21.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Cai Y, Alio del Barrio JL, Wilkins MR, Ang M. Serial optical coherence tomography angiography for corneal vascularization. Graefes Arch Clin Exp Ophthalmol. 2017;255(1):135–9.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Ang M, Cai Y, MacPhee B, Sim DA, Keane PA, Sng CCA, et al. Optical coherence tomography angiography and indocyanine green angiography for corneal vascularisation. Br J Ophthalmol. 2016;100(11):1557–63.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Hobart Clinical SchoolHobartAustralia
  2. 2.Singapore National Eye CentreSingaporeSingapore
  3. 3.Singapore Eye Research InstituteSingaporeSingapore
  4. 4.Singapore National Eye CentreSingaporeSingapore

Personalised recommendations